Skip to main content Skip to section navigation Skip to footer

ClearPoint Neuro, Inc.

Investor Relations

  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • clearpointneuro.com
This website uses cookies to improve your experience. ACCEPT REJECT

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Aug 09, 2022 4:15pm EDT

ClearPoint Neuro Reports Second Quarter 2022 Results

Aug 09, 2022 4:05pm EDT

ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model

Aug 08, 2022 4:05pm EDT

ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs

Jul 26, 2022 4:05pm EDT

ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022

Jul 21, 2022 4:20pm EDT

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency

Jun 29, 2022 4:05pm EDT

ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy

Jun 02, 2022 4:05pm EDT

ClearPoint Neuro Announces Receipt of MDSAP Certification

May 20, 2022 9:29am EDT

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency

May 13, 2022 9:25am EDT

ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC

May 11, 2022 4:05pm EDT

ClearPoint Neuro Reports First Quarter 2022 Results

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 30
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
ClearPoint Neuro, Inc. Youtube ClearPoint Neuro, Inc. Facebook ClearPoint Neuro, Inc. Twitter ClearPoint Neuro, Inc. LinkedIn ClearPoint Neuro, Inc. Instagram
©2023 ClearPoint Neuro, Inc. All Rights Reserved.
Privacy Policy Terms of Use California Compliance Declaration Sitemap